AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+11.67%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| 1 |
Hess Midstream
HESM
|
$148M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$106M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
$99.9M |
| 4 |
MPLX
MPLX
|
$76.6M |
| 5 |
Energy Transfer Partners
ET
|
$70.9M |
Top Sells
| 1 |
Western Midstream Partners
WES
|
$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
$338M |
| 3 |
Williams Companies
WMB
|
$39.2M |
| 4 |
Exxon Mobil
XOM
|
$31.4M |
| 5 |
Verizon
VZ
|
$24.2M |
Sector Composition
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Regenxbio
RGNX
$490M
| $1.47M | 0.02% |
44,138
-5,353
| -11% | -$178K |
|
|
AAT
277
American Assets Trust
AAT
$1.28B
| $1.43M | 0.02% |
37,734
-5,076
| -12% | -$192K |
|
278
Instil Bio
TIL
$213M
| $1.43M | 0.02% |
6,636
-824
| -11% | -$177K |
|
279
Hecla Mining
HL
$6.04B
| $1.42M | 0.02% |
216,010
+65,454
| +43% | +$430K |
|
280
Keros Therapeutics
KROS
$633M
| $1.34M | 0.01% |
24,671
-2,400
| -9% | -$131K |
|
281
American Superconductor
AMSC
$2.21B
| $1.33M | 0.01% |
174,911
-57,322
| -25% | -$436K |
|
282
Immunocore
IMCR
$1.87B
| $1.32M | 0.01% |
44,226
-6,444
| -13% | -$193K |
|
|
BDN
283
Brandywine Realty Trust
BDN
$759M
| $1.29M | 0.01% |
90,961
-10,801
| -11% | -$153K |
|
|
MYOV
284
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.29M | 0.01% |
96,505
-11,477
| -11% | -$153K |
|
285
ConocoPhillips
COP
$116B
| $1.28M | 0.01% |
12,835
+1,525
| +13% | +$153K |
|
286
Kinetik
KNTK
$2.58B
| $1.28M | 0.01% |
39,402
+29,754
| +308% | +$967K |
|
287
Catalyst Pharmaceutical
CPRX
$2.48B
| $1.26M | 0.01% |
152,241
-42,253
| -22% | -$350K |
|
288
StepStone Group
STEP
$4.78B
| $1.26M | 0.01% |
38,000
| – | – |
|
289
Recursion Pharmaceuticals
RXRX
$2.01B
| $1.24M | 0.01% |
173,678
-10,936
| -6% | -$78.3K |
|
290
AngloGold Ashanti
AU
$30.2B
| $1.23M | 0.01% |
51,731
+6,921
| +15% | +$164K |
|
291
Alector
ALEC
$305M
| $1.2M | 0.01% |
84,265
-9,791
| -10% | -$140K |
|
292
Merus
MRUS
$5.1B
| $1.18M | 0.01% |
44,683
-5,367
| -11% | -$142K |
|
293
LXP Industrial Trust
LXP
$2.71B
| $1.18M | 0.01% |
75,182
-9,909
| -12% | -$156K |
|
294
Protagonist Therapeutics
PTGX
$3.77B
| $1.18M | 0.01% |
49,760
-5,472
| -10% | -$130K |
|
295
JPMorgan Chase
JPM
$809B
| $1.16M | 0.01% |
8,520
-2,420
| -22% | -$330K |
|
|
296
Verizon
VZ
$187B
| $1.16M | 0.01% |
22,797
-475,005
| -95% | -$24.2M |
|
297
ADC Therapeutics
ADCT
$398M
| $1.16M | 0.01% |
78,845
-9,944
| -11% | -$146K |
|
298
FibroGen
FGEN
$48.9M
| $1.15M | 0.01% |
3,823
-469
| -11% | -$141K |
|
299
Humana
HUM
$37B
| $1.13M | 0.01% |
2,606
-335
| -11% | -$146K |
|
|
EFC
300
Ellington Financial
EFC
$1.38B
| $1.13M | 0.01% |
63,466
-8,029
| -11% | -$143K |
|